Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. Hosp. Ital. B. Aires (2004) ; 37(4): 142-145, dic. 2017. ilus
Artigo em Espanhol | LILACS | ID: biblio-1095740

RESUMO

La infección diseminada por Fusarium se ha convertido en un problema creciente en las personas con neoplasias hematológicas malignas, principalmente en pacientes con leucemias agudas; se describen cada vez más casos en aquellos sometidos a un trasplante de médula ósea. No existe un tratamiento óptimo establecido para la fusariosis diseminada. La mortalidad global comunicada de esta infección oscila entre el 50 y el 80%. Se presenta a continuación el caso de un paciente de sexo masculino de 29 años, con diagnóstico de leucemia mieloide aguda, que presenta como complicación una fusariosis diseminada, y logra sobrellevar un trasplante alogénico de médula ósea en el Hospital Italiano de San Justo (Argentina) de forma exitosa. (AU)


Disseminated fusariosis has become an increasing problem in people with hematopoietic neoplasms, mainly in patients affected by acute leukemias, and even more in those who undergo hematopoietic cell transplantation. There is not an optimal treatment for disseminated fusariosis. The global mortality described in the literature is between 50% and 80%. We introduce a case of a 29 year old patient with diagnosis of acute myeloid leukemia complicated with disseminated fusariosis, who copes with an allogeneic hematopoietic cell transplantation with a successful outcome in the "Hospital Italiano de San Justo" (Argentina). (AU)


Assuntos
Humanos , Masculino , Adulto , Leucemia Mieloide Aguda/cirurgia , Transplante de Medula Óssea/tendências , Fusariose/terapia , Azacitidina/efeitos adversos , Tabagismo , Transplante Homólogo , Leucemia Mieloide Aguda/complicações , Anfotericina B/administração & dosagem , Anfotericina B/uso terapêutico , Mitoxantrona/administração & dosagem , Mitoxantrona/uso terapêutico , Corticosteroides/uso terapêutico , Citarabina/administração & dosagem , Citarabina/uso terapêutico , Tomografia por Emissão de Pósitrons , Tratamento Farmacológico , Febre , Fusariose/microbiologia , Fusariose/mortalidade , Fusariose/epidemiologia , Fusariose/diagnóstico por imagem , Mialgia , Voriconazol/administração & dosagem , Voriconazol/uso terapêutico , Filgrastim/uso terapêutico , Uso da Maconha , Fumar Cocaína , Terbinafina/uso terapêutico , Melfalan/administração & dosagem , Melfalan/uso terapêutico , Antibacterianos/uso terapêutico
2.
Rev. bras. hematol. hemoter ; 33(5): 372-376, Oct. 2011. ilus, tab
Artigo em Inglês | LILACS | ID: lil-606714

RESUMO

BACKGROUND: Recently, the importance of cytogenetics has grown in the diagnosis, prognosis and treatment of leukemias and myelodysplastic syndromes. 5-azacytidine is a drug that has well-known cytogenetical effects and is approved in the treatment of myelodysplastic syndromes. To date, no studies have been performed to evaluate the impact of 5-azacytidine on the chromosomes of patients with hematological neoplasias. This study aimed to investigate the effects of 5-azacytidine on chromosomes of patients with different hematological malignancies using G-band analyses to identify possible cytogenetical alterations. METHODS: The peripheral blood of 18 patients with hematological malignancies and 18 controls was collected in heparinized tubes. 5-azacytidine was added, at a final concentration of 10-5M, to cultures 7 hours prior to harvest. RESULTS: Uncoiled centromeric/pericentromeric heterochromatin of chromosomes-1, 9 and 16 occurred more frequently in the patients than in controls. This higher frequency of uncoiled heterochromatin was statistically significant (p-value = 0.004) for chromosome-9. Conversely, we observed that the fragile site at 19q13 was more frequent in controls (p-value = 0.0468). CONCLUSIONS: The results of this study suggest that satellite sequences, located in the heterochromatin of chromosome-9, are hypomethylated in hematological malignancies. This hypomethylation may contribute to the disease, activating transposable elements and/or promoting genomic instability, enabling the loss of heterozygosity of important tumor suppressor genes. An investigation of the 19q13 region may help to understand whether or not the predominant occurrence of the fragile site at 19q13 in controls is due to hypermethylation of this region.


Assuntos
Humanos , Masculino , Feminino , Azacitidina/efeitos adversos , Análise Citogenética , Neoplasias Hematológicas , Heterocromatina , Leucemia , Síndromes Mielodisplásicas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA